Friday, October 21, 2022

Pfizer Plans to Hike Price of US COVID-19 Vaccine by 400 Percent

 Pfizer is looking to raise the price of COVID-19 vaccines by up to four times once Washington's purchase program ends

  • The federal government is paying roughly $30 per dose for the vaccine. When the government purchase program shuts down, Lukin expects a dose to be priced around $110 to $130.
  • In 2021, Pfizer made almost $37 billion through COVID vaccine sales, with overall revenues doubling to $81.3 billion. The company is expecting revenues to reach $98 billion to $102 billion this year.

Shrinking Market, Vaccine Dangers

  • Vaccine manufacturers will have to raise prices significantly to meet revenue expectations that Wall Street has for 2023 and the years ahead
  • There are also growing worries about the potential side effects of the COVID-19 vaccines which could dampen the market
  • Recently, Florida Surgeon General Dr. Joseph A. Ladapo issued new guidance on mRNA COVID vaccines like those manufactured by Pfizer

https://www.theepochtimes.com/pfizer-plans-to-hike-price-of-us-covid-19-vaccine-by-400-percent_4811658.html

No comments:

Post a Comment